Loading...
Loading...
CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure. Census population 577,222. Wisconsin Medicare wound biologics: National Government Services (NGS) (J6). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Milwaukee clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Milwaukee storefront.
Non-Surgical Joint Care Solutions in Milwaukee, WI for clinics & physicians. Non-surgical joint care with… Compliance support & pricing — contact Hawk Medical.
Adult obesity in Milwaukee is 41.8% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure. Wisconsin is outside CDC’s core Diabetes Belt list; use the PLACES city rate anyway. Hawk Medical is the distributor for non surgical joint care, not a walk-in clinic.
National Non-Surgical Joint Care Solutions notes (how the product actually works)J6 reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Milwaukee is 14.7% or not. PLACES is planning data. The LCD is the claim.
Vendor consolidation is boring on purpose: one account, IFUs filed, J6 articles mapped. 14.1% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 14.7% of adults — 2.7 points above the U.S. 12% figure. Obesity is 41.8%; arthritis is 23.8%. That is place-level BRFSS modeling, not a clinic census and not a Milwaukee trial.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what J6 reviewers and surveyors expect — not a brochure.
Yes — receiving, storage, indication, and documentation templates are part of onboarding. SOPs still have to be adopted as the clinic’s own procedures; we do not pretend to be the medical director in Milwaukee.
If you operate in Wisconsin and another MAC state, say it on the first call. J6 will not port 1:1. We would rather split utilization than watch a sister clinic copy Milwaukee tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Milwaukee, WI.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Milwaukee is J6 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Milwaukee — 2.7 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Wisconsin Part B wound biologics follow this contractor (siblings: IL, MN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Milwaukee. Useful for joint-program math; still needs a diagnosis and privileging.
No Milwaukee storefront. Joe Bradley is an active practice owner. non surgical joint care stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.